(Q53068177)

English

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).

scientific article published in March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study). (English)

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

George Davey Smith

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

7

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

Richard M Martin

object named as

Richard M Martin

8

0 references

Jenny L Donovan

4

object named as

Jenny L Donovan

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

6

object named as

Freddie C Hamdy

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

Janet Athene Lane

5

object named as

Janet Athene Lane

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

author name string

Ali S Murad

1

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

Liz Down

2

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

language of work or name

0 references

publication date

1 March 2011

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

International Journal of Cancer

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

128

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

6

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

1442-1448

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Inflammation in prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Cyclooxygenase-2 and prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Expression of cyclooxygenase-2 in prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Breast cancer and NSAID use: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Folic acid and risk of prostate cancer: results from a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Regular use of aspirin and prostate cancer risk (United States)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Aspirin use and chronic diseases: a cohort study of the elderly

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

COX-3: just another COX or the solitary elusive target of paracetamol?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Body mass index and risk of prostate cancer in U.S. health professionals

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Prostate-specific antigen and other prostate cancer markers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

How and why are non-prescription analgesics used in Scotland?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Prescription and nonprescription analgesic use in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Asymptomatic incidence and duration of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Screening for prostate cancer: an update

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Decision-Making about PSA Testing and Prostate Biopsies: A Qualitative Study Embedded in a Primary Care Randomised Trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25465

21 January 2018

Identifiers

10.1002/IJC.25465

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/20506261

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53068177&oldid=1858797112"